Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Product liability reform

This article was originally published in The Gray Sheet

Executive Summary

Compromise product liability agreement worked out between Senators Slade Gorton (R-Wash.) and John Rockefeller (D-W.Va.) "could be brought to the Senate floor in the near future and is expected to be signed by" President Clinton, the lawmakers say in a June 11 release. The bill would place a cap on punitive damages against small businesses (defined as having fewer than 25 employees and annual revenues of less than $5 mil.) of the lesser of two times compensatory damages or $250,000, provide for a two-year statute of limitations and mandate an 18-year statute of repose for durable workplace goods in which the plaintiff has received, or is eligible to receive, workers' compensation. Senate Majority Leader Trent Lott (R-Miss.) has not yet determined when the bill will be brought to the floor; such a move is not likely until debate on the tobacco bill (S 1415) has ended, Lott's staffers say
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT010205

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel